Nagase & Co. Ltd. is a US$6 billion per year global manufacturing/technology/trading company. Nagase possesses specialized technology and manufacturing capability for unnatural amino acids and other chiral molecules based on its proprietary biocatalysts and asymmetric catalysts. Process development, custom synthesis and cGMP contract manufacturing services are available beginning with multi-gram quantities at its Research Center through multi-kg process scale-up at its state-of-the-art pilot plant/semi-commercial facility to multi-ton quantities in its large-scale, GMP manufacturing facility. Nagase serves as an agent for other Asian fine chemical manufacturers and provides direct access to its partners’ technology and manufacturing capability.
